Overview

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Status:
Completed

Trial end date:
2004-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Cefprozil
Cephalosporins